483 Sun Pharmaceutical Industries Jul 2016

483 Sun Pharmaceutical Industries Jul 2016

Luis Dasta FDA$119.00 - Available Now

FDA investigators audited the Sun Pharmaceutical Industries - Ankleshwar, India facility and issued 3 inspectional observations (via FDA 483) on 29 Jul 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 29 Jul 2016
  • Location: Ankleshwar, India
  • FEI: 3012032037
Add To Cart